« Previous Next » Brachytherapy
Volume 5, Issue 1 , Pages 9-13 , January 2006

Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following ¹²⁵I prostate brachytherapy

Chandra Martens
- Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Greg Pond
- Department of Biostatistics, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Dennis Webster
- Department of Radiation Medicine, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Michael McLean
- Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Caitlin Gillan
- Department of Radiation Medicine, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Juanita Crook
- Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
- Corresponding author. Princess Margaret Hospital, 610 University Avenue, Toronto, Canada M5G 2M9. Tel.: +1-416-946-2919; fax: +1-416-946-2111.

Received 22 August 2005 ,Revised 29 November 2005 ,Accepted 1 December 2005.

References

Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 1996;14:449–453
- MEDLINE
Stokes SH, Real JD, Adams PW, et al. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1997;37:337–341
Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–1557
- MEDLINE
Lukka H, Warde P, Pickles T, et al. Controversies in prostate cancer radiotherapy: Consensus development. Canadian GU Radiation Oncologist Group. Can J Urol. 2001;8:1314–1322
- MEDLINE
Gelblum DY, Potters L, Ashley R, et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 1999;45:59–67
Crook J, Toi A, McLean M, et al. The utility of transition zone index in predicting acute urinary morbidity after iodine 125 prostate brachytherapy. Brachytherapy. 2002;1:131–137
Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 1998;160:1379–1382
Locke J, Ellis W, Wallner K, et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys. 2002;52:712–719
Lee N, Wuu CS, Brody R, et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48:1457–1460
Crook J, McLean M, Catton C, et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys. 2002;52:453–460
Bushkirk SJ, Pinkstaff DM, Petrou SP, et al. Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol Biol Phys. 2004;59:1360–1366
Williams SG, Millar JL, Duchesne GM, et al. Factors predicting for urinary morbidity following 125 iodine transperineal prostate brachytherapy. Radiother Oncol. 2004;73:33–38
Henderson A, Cahill D, Laing RW, et al. (125) Iodine prostate brachytherapy: Outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics. BJU Int. 2002;90:567–572
- MEDLINE
- CrossRef